Sortera Bio

Sortera Bio is a biotechnology company developing an AI-powered platform for the discovery and engineering of biological therapeutics.

The Deep Screening platform generates sequence and functional data across hundreds of millions of biologics in a single experiment, producing large-scale training datasets for generative AI models that predict novel, high-affinity biologic sequences.

The technology targets challenging biological targets including membrane proteins and is accessed by pharmaceutical partners through research collaborations.